Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Clinical research site in Baltimore, Maryland

Part of Johns Hopkins

As of July 2026, 19 paid clinical trials are recruiting at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. Active studies at this site cover conditions such as Breast Cancer, Kaposi Sarcoma and Lymphoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (19)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

169 locations incl. Daphne

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

43 locations incl. Tucson

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for Cachexia

81 locations incl. Birmingham

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06989437·Phase 2, Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for Low Grade Serous Ovarian Cancer

38 locations incl. Phoenix

Sponsor: Verastem, Inc.

Sex: Female·Age: 18+

Code: NCT06072781·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for Solid Tumors

13 locations incl. Phoenix

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT06179160·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

for Relapsed or Resistant Acute Leukaemias

5 locations incl. Tampa

Sponsor: Lin BioScience, Inc

Sex: All·Age: 18 - 120

Code: NCT05756322·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

for Myelodysplastic Syndromes

7 locations incl. Jacksonville

Sponsor: Syntrix Biosystems, Inc.

Sex: All·Age: 18+

Code: NCT04245397·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

for Prostate Cancer

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male·Age: 18+

Code: NCT06826924·Recruiting·Listed Feb 2025

Apply to this trial

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

for Cervical Cancer

2 locations incl. Birmingham

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female·Age: 18+

Code: NCT06315257·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

Cardiometabolic Screening Program

for Breast Cancer

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18+

Code: NCT05386719·Recruiting·Listed May 2022

Apply to this trial

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for Anal Carcinoma

8 locations incl. La Jolla

Sponsor: AIDS Malignancy Consortium

Sex: All·Age: 18+

Code: NCT05663502·Recruiting·Listed Dec 2022

Apply to this trial

Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia

for Chronic Myelomonocytic Leukemia

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18 - 100

Code: NCT07071155·EARLY_Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)

for Acute Leukemia

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: All ages

Code: NCT06803745·Recruiting·Listed Jan 2025

Apply to this trial

Trial of Ixazomib for Kaposi Sarcoma

for Kaposi Sarcoma

11 locations incl. San Diego

Sponsor: AIDS Malignancy Consortium

Sex: All·Age: 18+

Code: NCT04305691·Phase 2·Recruiting·Listed Mar 2020

Apply to this trial

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

for Prostate Cancer (Adenocarcinoma)

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male·Age: 18+

Code: NCT06616597·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Study in Patients With Breast Cancer Leptomeningeal Metastasis

for Leptomeningeal Metastasis of Breast Cancer

2 locations incl. Washington D.C.

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18 Weeks+

Code: NCT06638294·Recruiting·Listed Oct 2024

Apply to this trial

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

for Ovary Cancer

2 locations incl. Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female·Age: 18+

Code: NCT06617923·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

for Hematologic Malignancy

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18+

Code: NCT06398457·EARLY_Phase 1·Recruiting·Listed May 2024

Apply to this trial

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC

for Triple Negative Breast Cancer

2 locations in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female·Age: 18+

Code: NCT06245889·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

More research sites in Baltimore

Johns Hopkins University (185 trials)
Johns Hopkins Hospital (119 trials)
Johns Hopkins University/Sidney Kimmel Cancer Center (64 trials)
University of Maryland (59 trials)
University of Maryland Medical Center (52 trials)
Sinai Hospital of Baltimore (50 trials)
University of Maryland/Greenebaum Cancer Center (47 trials)
Johns Hopkins University School of Medicine (44 trials)
Johns Hopkins (38 trials)
Kennedy Krieger Institute (32 trials)

Explore more

Paid clinical trials in Baltimore, MD · Maryland clinical trials